Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentmyofibril

XIRP2 SYNE1 PDE4DIP

8.92e-04273153GO:0030016
GeneOntologyCellularComponentcontractile muscle fiber

XIRP2 SYNE1 PDE4DIP

1.06e-03290153GO:0043292
MousePhenoprolonged PR interval

XIRP2 SYNE1

3.13e-044292MP:0003896
MousePhenoprolonged QT interval

XIRP2 SYNE1

5.38e-045592MP:0003233
MousePhenoatrioventricular block

XIRP2 SYNE1

6.19e-045992MP:0010519
MousePhenoabnormal PR interval

XIRP2 SYNE1

7.50e-046592MP:0003901
MousePhenoabnormal QT interval

XIRP2 SYNE1

1.08e-037892MP:0003899
MousePhenoabnormal atrioventricular node conduction

XIRP2 SYNE1

1.22e-038392MP:0006141
MousePhenoheart block

XIRP2 SYNE1

2.83e-0312792MP:0010559
DomainSpectrin_repeat

EVPL SYNE1

2.41e-0429152IPR002017
DomainSpectrin/alpha-actinin

EVPL SYNE1

2.94e-0432152IPR018159
DomainSPEC

EVPL SYNE1

2.94e-0432152SM00150
DomainDisintegrin_dom

ADAM21 DUSP10

4.85e-0441152IPR001762
Pubmed

HENA, heterogeneous network-based data set for Alzheimer's disease.

SYNE1 ZFC3H1 PDE4DIP

1.77e-0512015331413325
Pubmed

Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.

XIRP2 SYNE1

3.28e-052015221689717
Pubmed

A human MAP kinase interactome.

CASP8AP2 EVPL SYNE1 DUSP10

4.55e-0548615420936779
Pubmed

Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.

XIRP2 SYNE1 PDE4DIP

1.27e-0423315337704626
InteractionGATM interactions

PDE4DIP DBT

2.83e-0511152int:GATM
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP DBT RMC1

3.33e-061771447555_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

ZNF268 DUSP10 PDE4DIP RMC1

3.96e-061851445908_UP
DrugCycloheximide [66-81-9]; Up 200; 14.2uM; PC3; HT_HG-U133A

ZNF268 SYNE1 DUSP10

1.13e-041581435743_UP
DrugFendiline hydrochloride [13636-18-5]; Up 200; 11.4uM; MCF7; HT_HG-U133A

ZNF268 DUSP10 PDE4DIP

1.26e-041641437188_UP
DrugSAHA; Up 200; 10uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.28e-041651434444_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.38e-041691434632_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.40e-041701436736_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.43e-041711434237_UP
DrugTrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.43e-041711434458_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.48e-041731437077_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.48e-041731437285_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.48e-041731437105_UP
Drug5255229; Up 200; 13uM; MCF7; HT_HG-U133A_EA

DUSP10 PDE4DIP DBT

1.48e-04173143949_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.53e-041751437245_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.53e-041751437073_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.55e-041761436439_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.55e-041761437047_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.58e-041771437387_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.58e-041771434665_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.61e-041781435940_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.63e-041791435086_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.66e-041801436340_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.66e-041801435950_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.66e-041801434344_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.71e-041821436316_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.71e-041821437503_UP
Drugtrichostatin A, Streptomyces sp.; Up 200; 1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.74e-041831435981_UP
Drugscriptaid; Up 200; 10uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.77e-041841436919_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.86e-041871436709_UP
DrugTrichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP RMC1

1.89e-041881435882_UP
DrugButylparaben [94-26-8]; Down 200; 20.6uM; PC3; HT_HG-U133A

DUSP10 PDE4DIP DBT

1.98e-041911434647_DN
DrugKetanserin tartrate hydrate [83846-83-7]; Down 200; 7uM; MCF7; HT_HG-U133A

DUSP10 PDE4DIP DBT

2.04e-041931433209_DN
DrugForskolin, from Coleus forskohlii; Down 200; 0.5uM; PC3; HT_HG-U133A

SYNE1 PDE4DIP DBT

2.04e-041931437059_DN
DrugIohexol [66108-95-0]; Up 200; 4.8uM; PC3; HT_HG-U133A

ZNF268 EVPL PDE4DIP

2.07e-041941434643_UP
DrugSulfachloropyridazine [80-32-0]; Down 200; 14uM; PC3; HT_HG-U133A

EVPL DUSP10 PDE4DIP

2.10e-041951434326_DN
DrugHecogenin [467-55-0]; Up 200; 9.2uM; MCF7; HT_HG-U133A

DUSP10 PDE4DIP DBT

2.10e-041951437175_UP
DrugMeticrane [1084-65-7]; Down 200; 14.6uM; MCF7; HT_HG-U133A

DUSP10 PDE4DIP DBT

2.13e-041961435984_DN
DrugHycanthone [3105-97-3]; Up 200; 11.2uM; PC3; HT_HG-U133A

ZNF268 DUSP10 PDE4DIP

2.13e-041961434630_UP
DrugGlibenclamide [10238-21-8]; Down 200; 8uM; MCF7; HT_HG-U133A

EVPL DUSP10 PDE4DIP

2.16e-041971437202_DN
DrugXylazine [7361-61-7]; Down 200; 18.2uM; PC3; HT_HG-U133A

ZNF268 SYNE1 PDE4DIP

2.16e-041971434066_DN
DrugVinpocetine [42971-09-5]; Down 200; 11.4uM; MCF7; HT_HG-U133A

ZNF268 DUSP10 PDE4DIP

2.16e-041971437213_DN
DrugMetformin hydrochloride [1115-70-4]; Down 200; 24.2uM; MCF7; HT_HG-U133A

DUSP10 PDE4DIP DBT

2.20e-041981431694_DN
DrugNadolol [42200-33-9]; Down 200; 13uM; PC3; HT_HG-U133A

ZNF268 EVPL DUSP10

2.20e-041981434021_DN
DrugFlufenamic acid [530-78-9]; Down 200; 14.2uM; PC3; HT_HG-U133A

EVPL SYNE1 DUSP10

2.20e-041981435059_DN
DrugAcetazolamide [59-66-5]; Up 200; 18uM; HL60; HT_HG-U133A

SYNE1 PDE4DIP DBT

2.20e-041981431850_UP
DrugDelsoline [509-18-2]; Down 200; 8.6uM; MCF7; HT_HG-U133A

EVPL DUSP10 PDE4DIP

2.23e-041991437212_DN
DrugCalycanthine [595-05-1]; Down 200; 11.6uM; MCF7; HT_HG-U133A

ZNF268 EVPL DUSP10

2.23e-041991436221_DN
Drug9H-carbazole

SYNE1 DBT

4.40e-0451142CID000006854
DrugAC1L1BIT

CASP8AP2 SYNE1

6.09e-0460142CID000001457
Drugthiophene

SYNE1 DBT

6.09e-0460142CID000008030
DrugAsbestos, Crocidolite

SYNE1 DUSP10 ZFC3H1 PDE4DIP DBT

6.32e-041241145ctd:D017638
Drugpropyl

SYNE1 DBT

8.52e-0471142CID000123145
Drugplakin

EVPL SYNE1

1.13e-0382142CID000018752
Diseasebipolar disorder (is_implicated_in)

DAOA SYNE1

9.72e-0529152DOID:3312 (is_implicated_in)

Protein segments in the cluster

PeptideGeneStartEntry
DAKSASQNCYKEINS

ADAM21

521

Q9UKJ8
CKKSEENYQDQNNSS

CASP8AP2

1211

Q9UKL3
NASVDENCQNITYKA

DBT

326

P11182
TYQDQKNKKANECSS

FAM47C

881

Q5HY64
TCNYNQQKDQSCNHK

DAOA

131

P59103
CTVATYDKDNQAQTQ

DUSP10

81

Q9Y6W6
QDAALTYQQFKNCKD

EVPL

746

Q92817
DYSKQCASTVQQQED

SYNE1

7246

Q8NF91
ENSACNKTKQNNEEF

TP53TG5

86

Q9Y2B4
YSQKEASNSQNSQAK

XIRP2

2221

A4UGR9
YECNECQKAFNTKSN

ZNF268

416

Q14587
DNSQLEYTQECKTKN

RMC1

96

Q96DM3
QNYSSKNENCVEETF

ZFC3H1

211

O60293
KNSRKTQDSYQNECA

ZMAT1

211

Q5H9K5
SYELKCAQESSQKQD

PDE4DIP

266

Q5VU43